Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

NCT05838625 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
464
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Click Therapeutics, Inc.

Collaborators